(R)-Naproxen

CAS No. 23979-41-1

(R)-Naproxen( —— )

Catalog No. M13692 CAS No. 23979-41-1

An anti-inflammatory agent with analgesic and antipyretic properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 43 In Stock
50MG 70 In Stock
100MG 105 In Stock
200MG 163 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (R)-Naproxen
  • Note
    Research use only, not for human use.
  • Brief Description
    An anti-inflammatory agent with analgesic and antipyretic properties.
  • Description
    An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. (In Vitro):l-Naproxen (30-1000 μM; 2 h) inhibits Rac1 and Cdc42 activity selectively in HeLa cells.l-Naproxen (0-300 μM; 48 h) inhibits migration of immortalized human ovarian cancer cells.l-Naproxen (300 μM; 48 h) shows activity via a COX-independent mechanism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23979-41-1
  • Formula Weight
    230.26
  • Molecular Formula
    C14H14O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    C[C@H](C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Albertini R, et al. Inflamm Res. 2007, 56(6):228-9.
molnova catalog
related products
  • Minoxidil

    Minoxidil(U 10858) is an antihypertensive vasodilator medication.

  • Orientin

    Orientin may be regarded as a candidate therapeutic agent for treatment of vascular inflammatory diseases via inhibition of the HMGB1 signaling pathway.

  • ATB 346

    ATB-346 is a novel hydrogen sulphide-releasing derivative of naproxen with markedly reduced toxicity.